3-[[4-(2-cyanophenyl)piperazin-1-yl]methyl]-1-methyl-5-(4-phenylpiperazine-1-carbonyl)pyrrole-2-carbonitrile

ID: ALA5220716

PubChem CID: 134515696

Max Phase: Preclinical

Molecular Formula: C29H31N7O

Molecular Weight: 493.62

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1c(C(=O)N2CCN(c3ccccc3)CC2)cc(CN2CCN(c3ccccc3C#N)CC2)c1C#N

Standard InChI:  InChI=1S/C29H31N7O/c1-32-27(29(37)36-17-15-34(16-18-36)25-8-3-2-4-9-25)19-24(28(32)21-31)22-33-11-13-35(14-12-33)26-10-6-5-7-23(26)20-30/h2-10,19H,11-18,22H2,1H3

Standard InChI Key:  YKMDFLBFXDXLSC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   -0.2985   -1.5801    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9660   -1.0952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7111   -0.3105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1139   -0.3105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3688   -1.0952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2985   -2.4053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1658   -1.3088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5264    0.4041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3516    0.4041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7642    1.1187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5894    1.1187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0019    0.4040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5894   -0.3105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7642   -0.3105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8271    0.4040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2399    1.1185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0626    1.1178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4753    0.4030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0662   -0.3088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2414   -0.3136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8289   -1.0282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7630   -1.3088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9766   -2.1058    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3465   -0.7253    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1436   -0.9388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7270   -0.3554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5135    0.4416    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7164    0.6552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1329    0.0717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0970    1.0251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9629   -1.5223    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.8941    0.8117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4753    1.3940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2616    2.1913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4690    2.4053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8824    1.8255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4163   -1.7428    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  1  6  1  0
  5  7  1  0
  4  8  1  0
  8  9  1  0
 10  9  1  0
 11 10  1  0
 12 11  1  0
 13 12  1  0
 14 13  1  0
  9 14  1  0
 12 15  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 15 20  1  0
 20 21  1  0
  2 22  1  0
 22 23  2  0
 22 24  1  0
 25 24  1  0
 26 25  1  0
 27 26  1  0
 28 27  1  0
 29 28  1  0
 24 29  1  0
 27 30  1  0
  7 31  3  0
 32 30  2  0
 33 32  1  0
 34 33  2  0
 35 34  1  0
 36 35  2  0
 30 36  1  0
 21 37  3  0
M  END

Alternative Forms

  1. Parent:

    ALA5220716

    ---

Associated Targets(Human)

MTOR Tclin mTORC1 (330 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin mTORC2 (162 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 493.62Molecular Weight (Monoisotopic): 493.2590AlogP: 3.05#Rotatable Bonds: 5
Polar Surface Area: 82.54Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.43CX LogP: 3.54CX LogD: 3.54
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.54Np Likeness Score: -1.50

References

1. Oleksak P, Nepovimova E, Chrienova Z, Musilek K, Patocka J, Kuca K..  (2022)  Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015-2021).,  238  [PMID:35688004] [10.1016/j.ejmech.2022.114498]

Source